Position in LLY
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$80,475,762
+$21,284,884 QoQ
Shares Held
67,095
+4.3% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.90%
of 13F equity value
Holder Rank
#425
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Sep 30, 2025CallValue
$0
CallShares
0
PutValue
$187,698
PutShares
246
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BANQUE PICTET & CIE SA holds $370,874,778 across 8 Drug Manufacturers - General names. LLY ranks #2 (21.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
409,324 | $103,002,291 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
67,095 | $80,475,762 | |
| 3 | MRK |
Merck & Co., Inc.
|
503,429 | $64,690,626 | |
| 4 | JNJ |
Johnson & Johnson
|
173,057 | $43,951,286 | |
| 5 | AZN |
Astrazeneca PLC
|
186,686 | $35,399,399 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
199,740 | $25,235,151 | |
| 7 | BIIB |
Biogen Inc.
|
65,080 | $14,061,184 | |
| 8 | NVO |
Novo Nordisk A S
|
84,670 | $4,059,079 |
All Filings in LLY
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $80,475,762 | 67,095 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $59,190,878 | 64,354 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $78,276,474 | 72,837 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $187,698 | 246 | Put | Sole | 2025-10-21 | |
| 2025-09-30 | $60,840,857 | 79,739 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $64,694,753 | 82,992 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $72,912,986 | 88,282 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $157,488 | 204 | Put | Sole | 2025-01-30 | |
| 2024-12-31 | $63,289,332 | 81,981 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $501,442 | 566 | Put | Sole | 2024-10-21 | |
| 2024-09-30 | $59,326,086 | 66,964 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $58,464,008 | 64,574 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $48,886,228 | 62,839 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $37,865,317 | 64,958 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $64,049,529 | 119,244 | Shares | Sole | 2023-11-27 | |
| 2023-06-30 | $60,048,199 | 128,040 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $32,773,944 | 95,434 | Shares | Sole | 2023-05-01 | |
| 2022-12-31 | $17,658,730 | 48,269 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $26,768,853 | 82,786 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $26,018,160 | 80,246 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $25,240,938 | 88,141 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $24,335,534 | 88,102 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $10,250,533 | 44,365 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $10,824,851 | 47,163 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $2,933,074 | 15,700 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $3,157,308 | 18,700 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,901,192 | 19,600 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $3,217,928 | 19,600 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,996,352 | 21,600 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||